GR3015840T3 - Use of tumor necrosis factor. - Google Patents
Use of tumor necrosis factor.Info
- Publication number
- GR3015840T3 GR3015840T3 GR950400970T GR950400970T GR3015840T3 GR 3015840 T3 GR3015840 T3 GR 3015840T3 GR 950400970 T GR950400970 T GR 950400970T GR 950400970 T GR950400970 T GR 950400970T GR 3015840 T3 GR3015840 T3 GR 3015840T3
- Authority
- GR
- Greece
- Prior art keywords
- necrosis factor
- tumor necrosis
- disease
- demyelinatig
- uveitis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
- Materials For Medical Uses (AREA)
- Telephonic Communication Services (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2056734A JPH03261726A (ja) | 1990-03-09 | 1990-03-09 | ぶどう膜炎治療用医薬組成物 |
JP2056735A JPH03261724A (ja) | 1990-03-09 | 1990-03-09 | 脱髄性疾患治療用医薬組成物 |
JP2056736A JPH03261725A (ja) | 1990-03-09 | 1990-03-09 | 移植片対宿主の疾患治療用医薬組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3015840T3 true GR3015840T3 (en) | 1995-07-31 |
Family
ID=27296018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR950400970T GR3015840T3 (en) | 1990-03-09 | 1995-04-17 | Use of tumor necrosis factor. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5190750A (el) |
EP (1) | EP0445894B1 (el) |
AT (1) | ATE118221T1 (el) |
AU (1) | AU633196B2 (el) |
CA (1) | CA2037831C (el) |
DE (2) | DE4107554A1 (el) |
DK (1) | DK0445894T3 (el) |
ES (1) | ES2067842T3 (el) |
FR (1) | FR2659235A1 (el) |
GB (1) | GB2241891B (el) |
GR (1) | GR3015840T3 (el) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994004121A1 (en) * | 1992-08-17 | 1994-03-03 | Autoimmune, Inc. | Bystander suppression of retroviral-associated neurological disease |
JPH09511990A (ja) * | 1994-04-08 | 1997-12-02 | ブリガム アンド ウィミンズ ホスピタル | 経口寛容および/またはTh2増強サイトカインを用いた自己免疫疾患の治療 |
NZ508878A (en) * | 1998-05-15 | 2003-08-29 | Genentech Inc | IL-17B and IL-17Cactive variants of IL-17 which stimulates epithelial, endothelial and fibroblastic cells |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62292727A (ja) * | 1986-06-12 | 1987-12-19 | Dainippon Pharmaceut Co Ltd | 癌壊死因子を有効成分とする鎮痛・消炎剤 |
JPS6330426A (ja) * | 1986-07-25 | 1988-02-09 | Mitsubishi Chem Ind Ltd | 自己免疫性疾患治療薬 |
DE3631413A1 (de) * | 1986-09-16 | 1988-03-24 | Knoll Ag | Therapeutisches system zur lokalen applikation von pharmawirkstoffen |
US4929442A (en) * | 1986-09-26 | 1990-05-29 | Exovir, Inc. | Compositions suitable for human topical application including a growth factor and/or related materials |
US4963354A (en) * | 1987-01-21 | 1990-10-16 | Genentech, Inc. | Use of tumor necrosis factor (TNF) as an adjuvant |
IL83878A (en) * | 1987-09-13 | 1995-07-31 | Yeda Res & Dev | Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it |
AU2844889A (en) * | 1988-01-22 | 1989-07-27 | Collagen Corporation | Method for suppressing the growth of normal and cancer cells |
DE3839639A1 (de) * | 1988-11-24 | 1990-05-31 | Basf Ag | Verwendung von tnf bei der behandlung von hautkrankheiten |
CA2003981C (en) * | 1988-12-27 | 2000-06-13 | Hiroshi Ishimaru | Pharmaceutical compositions and use thereof in the treatment of psoriasis |
-
1991
- 1991-03-07 US US07/665,876 patent/US5190750A/en not_active Expired - Lifetime
- 1991-03-07 FR FR9102732A patent/FR2659235A1/fr not_active Revoked
- 1991-03-08 DE DE4107554A patent/DE4107554A1/de not_active Withdrawn
- 1991-03-08 DK DK91200520.4T patent/DK0445894T3/da active
- 1991-03-08 ES ES91200520T patent/ES2067842T3/es not_active Expired - Lifetime
- 1991-03-08 CA CA002037831A patent/CA2037831C/en not_active Expired - Fee Related
- 1991-03-08 DE DE69107226T patent/DE69107226T2/de not_active Expired - Fee Related
- 1991-03-08 AT AT91200520T patent/ATE118221T1/de not_active IP Right Cessation
- 1991-03-08 AU AU72810/91A patent/AU633196B2/en not_active Ceased
- 1991-03-08 EP EP91200520A patent/EP0445894B1/en not_active Expired - Lifetime
- 1991-03-08 GB GB9104927A patent/GB2241891B/en not_active Revoked
-
1995
- 1995-04-17 GR GR950400970T patent/GR3015840T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0445894A2 (en) | 1991-09-11 |
GB9104927D0 (en) | 1991-04-24 |
EP0445894A3 (en) | 1992-01-02 |
AU7281091A (en) | 1991-09-12 |
CA2037831C (en) | 1997-01-21 |
DE69107226D1 (de) | 1995-03-23 |
ES2067842T3 (es) | 1995-04-01 |
GB2241891B (en) | 1994-05-25 |
FR2659235A1 (fr) | 1991-09-13 |
ATE118221T1 (de) | 1995-02-15 |
DE4107554A1 (de) | 1991-10-10 |
GB2241891A (en) | 1991-09-18 |
DK0445894T3 (da) | 1995-04-03 |
CA2037831A1 (en) | 1991-09-10 |
AU633196B2 (en) | 1993-01-21 |
US5190750A (en) | 1993-03-02 |
EP0445894B1 (en) | 1995-02-08 |
DE69107226T2 (de) | 1995-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
TW355683B (en) | Composition containing micronized nebivolol | |
CA2180535A1 (en) | A method for treatment of psoriasis, by omeprazole or related compounds | |
CA2041417A1 (en) | Treatment of pancreatic disease with 15-keto-prostaglandin compounds | |
GB9305295D0 (en) | Therapeutic compounds | |
GB9310095D0 (en) | Therapeutic compounds | |
CA2094275A1 (en) | Methods and compositions for the treatment of cell proliferation disorders | |
NO943288L (no) | Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer | |
CA2027814A1 (en) | Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds | |
SG47948A1 (en) | Compounds for the treatment of neurodegenerative disorders | |
MXPA02011533A (es) | Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona. | |
DE59001121D1 (en) | Antacidatabletten. | |
CA2042934A1 (en) | Treatment of ocular hypertension with an ocular synergistic combination | |
CA2135179A1 (en) | Pharmaceutical Compositions of Alkylsulphonamides 5HT1 Agonists for Rectal Administration | |
GR3015840T3 (en) | Use of tumor necrosis factor. | |
AU4685389A (en) | Pharmaceutical compositions and use thereof in the treatment of psoriasis | |
AU8447991A (en) | Antineoplastic effect potentiator and antineoplastic agent | |
CA2030344A1 (en) | Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds | |
CA2042936A1 (en) | Treatment of ocular hypertension with a synergistic combination for ophthalmic use | |
CA2041240A1 (en) | Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds | |
CA2048245A1 (en) | Treatment of cataract with prostacyclin compounds | |
AU658197B2 (en) | New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives | |
CA2392902A1 (en) | Substituted bisindolylmaleimides for the inhibition of cell proliferation | |
AP9200405A0 (en) | Pharmaceutical formulations comprised of micronised halofantrine. | |
IT1264428B1 (it) | Composizioni farmaceutiche per il trattamento della psoriasi |